Matches inside:

Our research revealed that the bioprinting field has advanced rapidly in the past two decades and is close to creating tissue products with high commercial and therapeutic value. We found that the commercial adoption of bioprinted products will likely occur for in vitro tissue models first, within 5-10 years, for simple tissue grafts like skin and bone second, in 10- 15 years, followed by vascularized patches and functional organ regeneration implants third, in 20-25 years, and organ transplants last, 3-4 decades in the future.